Search Results - "Jabłonowska, E"

Acquired immune deficiency syndrome (AIDS) and late presentation in Poland – data from Test and Keep in Care (TAK) Polska project by Jabłonowska, E, Szetela, B, Bielecki, M, Horban, A, Bociąga‐Jasik, M, Mularska, E, Hlebowicz, M, Olczak, A, Parczewski, M, Grzeszczuk, A, Bielec, D, Cybula, A, Kocbach‐Przudzik, A, Ankiersztejn‐Bartczak, M, Kowalska, JD

“…Objectives Late presentation (LP) at HIV diagnosis is associated with worse prognosis and an increase in the number of new infections. We analyse the…”
Get full text

Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study by Piekarska, A., Jabłonowska, E., Garlicki, A., Sitko, M., Mazur, W., Jaroszewicz, J., Czauz-Andrzejuk, A., Buczyńska, I., Simon, K., Lorenc, B., Dybowska, D., Halota, W., Pawłowska, M., Dobracka, B., Berak, H., Horban, A., Tudrujek-Zdunek, M., Tomasiewicz, K., Janczewska, E., Socha, Ł., Laurans, Ł., Parczewski, M., Zarębska-Michaluk, D., Pabjan, P., Belica-Wdowik, T., Baka-Ćwierz, B., Deroń, Z., Krygier, R., Klapaczyński, J., Citko, J., Berkan-Kawińska, A., Flisiak, R.

“…The aim of this study was to evaluate the baseline demographics and real-life efficacy of direct acting antivirals (DAAs) in HIV-HCV-positive patients as…”
Get full text

Long‐term trends in HIV care entry: over 15 years of clinical experience from Poland by Siwak, E, Horban, A, Witak‐Jędra, M, Cielniak, I, Firląg‐Burkacka, E, Leszczyszyn‐Pynka, M, Witor, A, Muller, K, Bociąga‐Jasik, M, Kalinowska‐Nowak, A, Gąsiorowski, J, Szetela, B, Jabłonowska, E, Wójcik‐Cichy, K, Jankowska, J, Lemańska, M, Olczak, A, Grąbczewska, E, Grzeszczuk, A, Rogalska‐Plonska, M, Suchacz, M, Mikuła, T, Łojewski, W, Bielec, D, Kocbach, P, Błudzin, W, Parczewski, M

“…Introduction Delay in HIV diagnosis and consequently late care entry with low CD4 counts remain a major challenge for the control of the HIV/AIDS epidemic. The…”
Get full text

Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation by Jabłonowska, E, Kuydowicz, J

“…The aim of this study was to estimate the prevalence of total antibodies to hepatitis A virus (anti-HAV-T) in the group of HIV-positive adults in Lodz region…”
Get more information

Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors by Flisiak, R, Wiercińska-Drapało, A, Bociąga-Jasik, M, Barałkiewicz, G, Grzeszczuk, A, Olczak, A, Grąbczewska, E, Parczewski, M, Jabłonowska, E, Dąbrowska, M, Kozłowska, J, Mikuła, T, Witor, A, Gąsiorowski, J, Latarska-Smuga, D, Ścibiorski, C, Knysz, B

“…Abstract Aim Aim of this study was to evaluate cardiovascular risk in HIV-infected patients treated with atazanavir or lopinavir, both boosted with ritonavir,…”
Get full text

Synthesis, characterization, and electrochemical testing of carbon nanotubes derivatized with azobenzene and anthraquinone by Sadowska, K., Roberts, K.P., Wiser, R., Biernat, J.F., Jabłonowska, E., Bilewicz, R.

“…Multi-walled and single-walled carbon nanotubes were side-wall functionalized with azobenzene and anthraquinone residues, i.e., chemical groups possessing…”
Get full text

HIV patients in the glaring light of the new ESC dyslipidaemias 2019 guidelines. Unattainable goals or a therapeutic nihilism? by Sanetra, A., Wlazłowska, E., Jabłonowska, E., Broncel, M., Gorzelak-Pabis, P.

Get full text

Observational cohort study of rilpivirine (RPV) utilization in Europe by Cozzi-Lepri, Alessandro, Peters, Lars, Pelchen-Matthews, Annegret, Neesgaard, Bastian, De Wit, Stephane, Johansen, Isik Somuncu, Edwards, Simon, Stephan, Christoph, Adamis, Georgios, Staub, Therese, Zagalo, Alexandra, Domingo, Pere, Elbirt, Daniel, Kusejko, Katharina, Brännström, Johanna, Paduta, Dzmitry, Trofimova, Tatyana, Szlavik, Janos, Zilmer, Kai, Losso, Marcello, Van Eygen, Veerle, Pai, Helen, Lundgren, Jens, Mocroft, Amanda

“…Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce…”
Get full text

Establishing a hepatitis C continuum of care among HIV/hepatitis C virus‐coinfected individuals in EuroSIDA by Peters, L, Sluzhynska, M, Scherrer, A, Domingo, P, Gerstoft, J, Viard, JP, Leen, C, Jablonowska, E, Wandeler, G, Falconer, K, D'Arminio Monforte, A, Rockstroh, JK, Lundgren, JD, Mocroft, A, Kundro, M, Schmied, B, Paduto, D, Clumeck, N, De Wit, S, Vandekerckhove, L, Johansen, IS, Wiese, L, Moller, NF, Aho, I, Pradier, C, Bogner, J, Xylomenos, G, Armenis, K, Sambatakou, H, Szlávik, J, Mulcahy, F, Yust, I, Burke, M, Hassoun, G, Elinav, H, Haouzi, M, Elbirt, D, Sthoeger, ZM, Esposito, R, Mazzotta, F, Vullo, V, Antinori, A, Acinapura, R, Plazzi, M, Castagna, A, Gianotti, N, Rozentale, B, Uzdaviniene, V, Staub, T, Reikvam, DH, Bruun, J, Gasiorowski, J, Bakowska, E, Parczewski, M, Beniowski, M, Smiatacz, T, Wojcik, K, Caldeira, L, Mansinho, K, Maltez, F, Radoi, R, Trofimora, T, Khromova, I, Kuzovatova, E, Borodulina, E, Jevtovic, D, Tomazic, J, Laguno, M., Martinez, E., Garcia, F., Martinez‐Rebollar, M., Moreno, S, Rodriguez, JM, Clotet, B, Paredes, R, Puig, J, Gutierrez, M, Mateo, G, Treutiger, CJ, Flamholc, L, Weber, R, Furrer, H, Schmid, P, Kuznetsova, A, Kyselyova, G, Gazzard, B, Johnson, AM, Simons, E, Edwards, S, Phillips, A, Weber, J, Clarke, A, Svedhem, V, Kowalska, JD, Guaraldi, G, Kirk, O, Bojesen, A, Raben, D, Laut, K, Nykjær, B

“…Objectives The aim of the study was to establish a methodology for evaluating the hepatitis C continuum of care in HIV/hepatitis C virus (HCV)‐coinfected…”
Get full text

HIV-1 drug resistance patterns among treatment-naïve and therapy-experienced patients in Poland by Stańczak, G.P, Stańczak, J.J, Majchrzak, M.J, Burkacka, E, Wiercińska-Drapało, A, Leszczyszyn-Pynka, M, Jabłonowska, E, Małolepsza, E, Horban, A

“…Summary Background HIV-1 drug resistance (DR) is becoming a growing concern. It is estimated that about one out of ten newly HIV-infected persons in Europe…”
Get full text

HIV patients at the crossroads of European cardiovascular recommendations. Which path they should follow? by Sanetra, A, Gorzelak-Pabis, P, Wlazlowska, E, Jablonowska, E, Broncel, M

Get full text

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe by Hofstra, L. Marije, Sauvageot, Nicolas, Albert, Jan, Alexiev, Ivailo, Garcia, Federico, Struck, Daniel, Van de Vijver, David A. M. C., Åsjȯ, Birgitta, Beshkov, Danail, Coughlan, Suzie, Descamps, Diane, Griskevicius, Algirdas, Hamouda, Osamah, Horban, Andrzej, Van Kasteren, Marjo, Kolupajeva, Tatjana, Kostrikis, Leondios G., Liitsola, Kirsi, Linka, Marek, Mor, Orna, Nielsen, Claus, Otelea, Dan, Paraskevis, Dimitrios, Paredes, Roger, Poljak, Mario, Puchhammer-Stöckl, Elisabeth, Sönnerborg, Anders, Staneková, Danica, Stanojevic, Maja, Van Laethem, Kristel, Zazzi, Maurizio, Lepej, Snjezana Zidovec, Boucher, Charles A. B., Schmit, Jean-Claude, Wensing, Annemarie M. J.

“…Background. Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines…”
Get full text

Hepatitis delta infection among persons living with HIV in Europe by Béguelin, Charles, Boyd, Anders, Falconer, Karolin, Suter‐Riniker, Franziska, Rockstroh, Jürgen K., Mocroft, Amanda, Rauch, Andri, Peters, Lars, Aebi‐Popp, K., Anagnostopoulos, A., Battegay, M., Braun, D. L., Bucher, H. C., Dollenmaier, G., Egger, M., Elzi, L., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Keiser, O, Martinetti, G., Metzner, K. J., Pantaleo, G., Perreau, M., Schmid, P., Stöckle, M., Wandeler, G., Kundro, M., Schmied, B., Paduto, D., Clumeck, N., Florence, E, Sedlacek, D., Kronborg, G., Pedersen, C., Ostergaard, L., Nielsen, L. N., Aho, I., Lacombe, K., Degen, O., Hoffmann, C., Stellbrink, H. J., Chkhartishvili, N., Sambatakou, H., Adamis, G., Paissios, N., Gottfredsson, M., Tau, L., Elbirt, D., D’Arminio Monforte, A., Guaraldi, G., Mazeu, I., Mussini, C., Gabbuti, A., Lazzarin, A., Castagna, A., Gianotti, N., Bruun, J., Knysz, B., Bakowska, E., Maciejewska, K., Aksak‐Was, B., Beniowski, M., Kamerys, J., Mansinho, K., Maltez, F., Gusev, D., Khromova, I., Vdoushkina, E., Ranin, J., Laguno, M., Mallolas, J., Rojas, J., Jou, A., Santos, J. R., Sönnerborg, A., Kusejko, K., Cavassini, M., Schmid, P., Kuznetsova, A., Johnson, M. A., Winston, A., Clarke, A., Karpov, I., Losso, M., Lundgren, J., Pradier, C., Chkhartishvili, N., Miró, J. M., Paredes, R., Peters, L., Jaschinski, N., Fursa, O., Raben, D., Kristensen, D., Ahmed, A, Mocroft, A., Reekie, J., Tusch, E. S.

“…Background and Aims A high prevalence of hepatitis delta virus (HDV) infection, the most severe form of viral hepatitis, has been reported among persons living…”
Get full text

Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort by Pelchen-Matthews, Annegret, Borges, Álvaro H., Reekie, Joanne, Rasmussen, Line D., Wiese, Lothar, Weber, Jonathan, Pradier, Christian, Degen, Olaf, Paredes, Roger, Tau, Luba, Flamholc, Leo, Gottfredsson, Magnus, Kowalska, Justyna, Jablonowska, Elzbieta, Mozer-Lisewska, Iwona, Radoi, Roxana, Vasylyev, Marta, Kuznetsova, Anastasiia, Begovac, Josip, Svedhem, Veronica, Clark, Andrew, Cozzi-Lepri, Alessandro

“…Although antiretroviral treatments have improved survival of persons living with HIV, their long-term use may limit available drug options. We estimated the…”
Get full text

Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study by Amele, Sarah, Peters, Lars, Rodger, Alison, Lundgren, Jens, Rockstroh, Jurgen, Matulionyte, Raimonda, Leen, Clifford, Jabłonowska, Elzbieta, Østergaard, Lars, Bhagani, Sanjay, Sarcletti, Mario, Clarke, Amanda, Falconer, Karolin, Wandeler, Gilles, Domingo, Pere, Maltez, Fernando, Zaccarelli, Mauro, Chkhartisvili, Nikoloz, Szlavik, Janos, Stephan, Christoph, Fonquernie, Laurent, Aho, Inka, Mocroft, Amanda

“…To investigate the effectiveness, safety, and reasons for premature discontinuation of direct-acting antivirals (DAAs) in a diverse population of HIV/hepatitis…”
Get full text

Infection‐related and ‐unrelated malignancies, HIV and the aging population by Borges, ÁH, Ledergerber, B, Domingo, P, Knysz, B, Karpov, I, Kirk, O, Lundgren, J, Clumeck, N., Vandekerckhove, L., Machala, L., Kronborg, G., Larsen, M., Gerstoft, J., Katzenstein, T., Skinhøj, P., Pedersen, C., Dragsted, U. B., Zilmer, K., Girard, P‐M., Vanhems, P., Pradier, C., Neau, D., Schmidt, R., Lunzen, J., Stellbrink, H. J., Bickel, M., Fätkenheuer, G., Kosmidis, J., Gargalianos, P., Perdios, J., Gottfredsson, M., Burke, M., Pollack, S., Hassoun, G., Haouzi, M., Esposito, R., Arici, C., Pristera, R., Mazzotta, F., Montesarchio, E., Gargiulo, M., D'Offizi, G., Taibi, C., Antinori, A., Lazzarin, A., Ridolfo, A., Chaplinskas, S., Reiss, P., Ormaasen, V., Boron‐Kaczmarska, A., Pynka, M., Parczewski, M., Mularska, E., Jablonowska, E., Wojcik, K., Doroana, M., Caldeira, L., Maltez, F., Duiculescu, D., Rakhmanova, A., Buzunova, S., Jevtovic, D., Mokráš, M., Staneková, D., Rodriguez, J. M., Bravo, I., Gatell, J. M., Medrano, J., Flamholc, L., Weber, R., Francioli, P., Cavassini, M., Boffi, E., Battegay, M., Elzi, L., Kravchenko, E., Frolov, V., Kutsyna, G., Servitskiy, S., Kuznetsova, A., Kyselyova, G., Simons, E., Orkin, C., Fisher, M., Horban, A., Pedersen, C., Rakhmanova, A., Phillips, A., Cozzi‐Lepri, A., Grint, D., Schultze, A., Raben, D., Kjær, J., Fischer, A. H., Grarup, J., Thiebaut, R., Burger, D., Paredes, R., Kjær, J., Peters, L.

“…Objectives HIV‐positive people have increased risk of infection‐related malignancies (IRMs) and infection‐unrelated malignancies (IURMs). The aim of the study…”
Get full text

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe by Sandri, Anastasia Karachalia, Rodger, Alison, Benfield, Thomas, Milinkovic, Ana, Stellbrink, Hans‐Jürgen, Sambatakou, Helen, Caldeira, Luis, Laguno, Monserrat, Gisinger, Martin, Rockstroh, Jürgen Kurt, Mocroft, Amanda, Losso, M, Kundro, M, Schmied, B, Vassilenko, A, Mitsura, VM, Wit, S De, Vandekerckhove, L, Begovac, J, Jilich, D, Sedlacek, D, Kronborg, G, Benfield, T, Katzenstein, T, Pedersen, C, Moller, NF, Nielsen, L N, Zilmer, K, Viard, J‐P, Girard, P‐M, Fontas, E, Behrens, G, Fätkenheuer, G., Sambatakou, H, Szlávik, J, Gottfredsson, M, Devitt, E, Hassoun, G, Elinav, H, Haouzi, M, Esposito, R, Mussini, C, Mazzotta, F, Ridolfo, A, Staub, T, Hemmer, R, Dragas, S, Reiss, P, Reikvam, DH, Gasiorowski, J, Inglot, M, Mozer‐Lisewska, I, Rozplochowski, B, Mansinho, K, Oprea, C, Davila, Carol, Yakovlev, A, Blokhina, I.N., Novogrod, Nizhny, Borodulina, E, Ranin, J, Tomazic, J, Miró, JM, Martinez, E, Martinez‐Rebollar, M, Mallolas, J, Clotet, B, Jou, A, Llibre, JM, Gutierrez, M, Mateo, G, Falconer, K, Flamholc, L, Cavassini, M, Battegay, M, Schmid, P, Milinkovic, A, Johnson, AM, Simons, E, Edwards, S, Mocroft, A, Leen, C, Karpov, I, Aho, I, Svedhem, V, Pradier, C, Chkhartishvili, N, Kowalska, JD, Wandeler, G, Paredes, R, Kirk, O, Peters, L, Bojesen, A, Raben, D, Hansen, EV, Larsen, JF, Cozzi‐Lepri, A, Pelchen‐Matthews, A, Roen, A, Reekie, J

“…Objectives Although direct‐acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV‐coinfected individuals, high rates of reinfection may hamper efforts to…”
Get full text

The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study by Mocroft, Amanda, Miro, Jose M., Wandeler, Gilles, Boyd, Anders, Bremen, Kathrin, Beniowski, Marek, Mikhalik, Julia, Duvivier, Claudine, Knysz, Brygida, Bakowska, Elzbieta, Viard, Jean‐Paul, Milinkovic, Ana, Benfield, Thomas, Harxhi, A., Losso, M., Kundro, M., Schmied, B., Karpov, I., Vassilenko, A., Mitsura, V. M., Florence, E., Sedlacek, D., Gerstoft, J., Katzenstein, T., Johansen, I. S., Wiese, L., Zilmer, K., Aho, I., Lacombe, K., Fontas, E., Rockstroh, J., Behrens, G., Stellbrink, H. J., Sambatakou, H., Gottfredsson, M., Devitt, E., Turner, D., Burke, M., Shahar, E., Haouzi, M., Esposito, R., Castagna, A., Gianotti, N., Staub, T., Hemmer, R., vd Valk, M., Maeland, A., Inglot, M., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Mularska, E., Jablonowska, E., Kamerys, J., Mozer‐Lisewska, I., Rozplochowski, B., Oprea, C., Gusev, D., Trofimova, T., Borodulina, E., Ranin, J., Miró, J. M., Laguno, M., Garcia, F., Martinez‐Rebollar, M., Mallolas, J., Jou, A., Paredes, R., Mateo, G., Sambeat, M. A., Svedhem, V., Flamholc, L., Kusejko, K., Braun, D., Calmy, A., Battegay, M., Simons, E., Edwards, S., Clarke, A., Losso, M., Lundgren, J., Rockstroh, J., Aho, I., Svedhem, V., Chkhartishvili, N., Matulionyte, R., Kowalska, J. D., Begovac, J., Miró, J. M., Paredes, R., Paredes, R., Larsen, J. F., Neesgaard, B., Fursa, O., Hansen, E. V., Fischer, A. H., Jensen, S. K., Pelchen‐Matthews, A., Tusch, E. S., Bannister, W.

“…Objectives The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non‐liver malignancies in people living with HIV (PLWH)…”
Get full text

Establishing a hepatitis C continuum of care among HIV /hepatitis C virus‐coinfected individuals in Euro SIDA by Amele, S, Peters, L, Sluzhynska, M, Yakovlev, A, Scherrer, A, Domingo, P, Gerstoft, J, Viard, JP, Gisinger, M, Flisiak, R, Bhaghani, S, Ristola, M, Leen, C, Jablonowska, E, Wandeler, G, Stellbrink, H, Falconer, K, D'Arminio Monforte, A, Horban, A, Rockstroh, JK, Lundgren, JD, Mocroft, A

Get full text

The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people by Shepherd, L, Bower, M, Silverberg, M, Ristola, M, Mussini, C, Mansinho, K, Yust, I, Paduta, D, Jilich, D, Smiatacz, T, Tomazic, J, Plomgaard, P, Lundgren, J, Mocroft, A, Schmied, B, Paduto, D, Clumeck, N, De Wit, S, Vandekerckhove, L, Machala, L, Gerstoft, J, Ostergaard, L, Wiese, L, Zilmer, K, Jelena Smidt, Ristola, M, Duvivier, C, Rockstroh, J, Degen, O, Stellbrink, HJ, Stefan, C, Sambatakou, H, Mulcahy, F, Turner, D, Burke, M, Shahar, E, Elbirt, D, D'Arminio Monforte, A, Esposito, R, Mazeu, I, Vullo, V, Lichtner, M, Antinori, A, Lazzarin, A, Castagna, A, Gianotti, N, Galli, M, Matulionyte, R, Reiss, P, Knysz, B, Gasiorowski, J, Bakowska, E, Flisiak, R, Maciejewska, K, Aksak‐Was, B, Beniowski, M, Mularska, E, Gensing, M, Jablonowska, E, Malolepsza, E, Wojcik, K, Maltez, F, Oprea, C, Panteleev, O, Yakovlev, A, Kuzovatova, E, Borodulina, E, Jevtovic, D, Gatell, JM, Miró, JM, Moreno, S, Clotet, B, Sambeat, MA, Laporte, JM, Sonnerborg, A, Blaxhult, A, Scherrer, A, Cavassini, M, Calmy, A, Furrer, H, Schmid, P, Kuznetsova, A, Sluzhynska, M, Simons, E, Edwards, S, Johnson, MA, Orkin, C, Scullard, G, Gatell, J, Gazzard, B, Horban, A, d'Arminio Monforte, A, Rockstroh, J, Rockstroh, J, Kirk, O, Kirk, O, Fischer, AH, Bojesen, A, Raben, D, Kristensen, D

“…Objectives B‐cell dysfunction and activation are thought to contribute to lymphoma development in HIV‐positive people; however, the mechanisms are not well…”
Get full text